Breztri is a maintenance inhaler for chronic obstructive pulmonary disease (COPD), not asthma, because the two conditions require different long-term treatments

Breztri (budesonide/glycopyrrolate/formoterol) is approved only for COPD, a progressive lung disease most commonly caused by smoking. Asthma and COPD are separate conditions that damage the airways in different ways, so the medications that work best for each are different. Breztri contains three active ingredients designed specifically to address how COPD damages the lungs—not how asthma does. Using the wrong maintenance inhaler for your condition means you won't get the right protection, even if the inhaler reaches your lungs.

If you have asthma and someone suggested Breztri, or if you're unsure whether you have asthma or COPD, this matters for your treatment plan. The distinction between the two conditions is real, and your doctor will have prescribed the inhaler that matches your diagnosis.

Key Takeaways

  • Breztri is approved by the FDA only for COPD maintenance treatment, not for asthma of any severity.
  • Asthma and COPD are different diseases with different underlying causes, so they respond to different maintenance inhalers.
  • Asthma maintenance inhalers typically contain an inhaled corticosteroid, often combined with a long-acting bronchodilator, but not the three-drug combination in Breztri.
  • Using a medication not approved for your condition means you may not receive adequate protection and could face unexpected side effects.
  • If you have questions about whether your current inhaler is right for you, your prescribing doctor or pharmacist can explain why that specific inhaler was chosen.

How asthma and COPD damage the lungs differently

Asthma is a condition where the airways become inflamed and narrow in response to triggers—allergens, exercise, cold air, or infections. The inflammation is reversible: when the trigger goes away or you use a rescue inhaler, the airways open back up. Asthma can start at any age and often runs in families. The underlying problem is overreactive airways, not permanent damage.

COPD is a progressive disease where the lungs lose function over time, usually from years of smoking or long-term exposure to irritants. The damage is largely permanent. In COPD, the small air sacs in the lungs break down (emphysema), the airways become thick and clogged with mucus (chronic bronchitis), or both. The airflow obstruction does not fully reverse, even with medication. COPD gets worse over time without treatment, but the right medications can slow that decline and reduce symptoms.

Because the diseases work differently, the maintenance inhalers work differently too. Asthma maintenance inhalers aim to prevent inflammation and keep airways from reacting to triggers. COPD maintenance inhalers aim to open the airways, reduce mucus, and prevent the inflammation that accelerates lung damage. Breztri was designed for the COPD pattern, not the asthma pattern.

What Breztri contains and why it is built for COPD

Breztri is a combination inhaler with three medications: budesonide (an inhaled corticosteroid), glycopyrrolate (an anticholinergic), and formoterol (a long-acting beta-agonist). Each ingredient addresses a specific problem in COPD.

The budesonide reduces inflammation in the airways. The glycopyrrolate relaxes the muscles around the airways and also dries up excess mucus—a major problem in COPD but not the primary target in asthma. The formoterol keeps the airways open for 12 hours. Together, these three drugs address the way COPD damages the lungs: inflammation, mucus buildup, and airway narrowing.

Asthma maintenance inhalers typically contain an inhaled corticosteroid alone (like fluticasone or budesonide) or combined with a long-acting beta-agonist (like fluticasone/salmeterol or budesonide/formoterol). They do not include an anticholinergic like glycopyrrolate, because drying up mucus is not the primary goal in asthma. The standard asthma inhalers are designed to prevent the inflammation and airway reactivity that define asthma.

FDA approval is specific to each disease

The FDA approves medications for specific conditions based on clinical trials that test whether the drug works for that disease. Breztri was tested in people with COPD, and the trials showed it reduced symptoms and slowed lung function decline in that population. The FDA approved it for COPD maintenance only.

A medication is not approved for a condition simply because it contains ingredients that appear in other approved drugs. Even if one ingredient in Breztri is used in asthma inhalers, the combination and the dosing are designed for COPD. Prescribing a medication outside its approved use is called off-label prescribing, and while doctors can do this in certain situations, it is not standard practice for asthma when approved asthma inhalers exist.

If your doctor prescribed Breztri and you have asthma, ask them to clarify your diagnosis. It is possible you have been diagnosed with COPD, or with both asthma and COPD (a condition called asthma-COPD overlap). Your doctor will explain which condition applies to you and why that specific inhaler was chosen.

What maintenance inhalers are used for asthma instead

Asthma maintenance inhalers fall into a few standard categories. The most common are inhaled corticosteroids alone—fluticasone (Flovent), budesonide (Pulmicort), or beclomethasone—taken once or twice daily. These reduce inflammation and are the first-line maintenance treatment for persistent asthma.

For moderate to severe asthma, doctors often prescribe a combination inhaler with an inhaled corticosteroid plus a long-acting beta-agonist. Examples include fluticasone/salmeterol (Advair), budesonide/formoterol (Symbicort), and mometasone/formoterol (Dulera). These are taken once or twice daily depending on the specific inhaler.

For severe asthma that does not respond to standard inhalers, other options exist—including other combination inhalers, add-on medications, or biologic drugs given by injection. Your doctor will choose based on your asthma severity, how often you have symptoms, and how well you respond to treatment. If your current inhaler is not controlling your asthma, tell your doctor so they can adjust your plan.

What to do if you are confused about your inhaler

If you received a prescription for Breztri and you believe you have asthma, contact your prescribing doctor or your pharmacist before using it. Explain your concern. They can tell you whether your diagnosis is actually COPD, asthma-COPD overlap, or something else, and they can explain why that specific inhaler was prescribed.

If you have been using Breztri and it is not controlling your symptoms, or if you are having side effects, report this to your doctor. Do not stop using your inhaler on your own, because that leaves you without protection. Instead, schedule a call or visit to discuss whether a different maintenance inhaler would work better for you.

Keep a record of your diagnosis and the names of your maintenance and rescue inhalers. If you see a new doctor or go to an urgent care clinic, having this information ready helps them understand your condition and avoid prescribing something that conflicts with your current treatment.

Frequently Asked Questions

Can someone have both asthma and COPD at the same time?

Yes. Asthma-COPD overlap (ACO) is a condition where a person has features of both diseases. People with ACO may need a maintenance inhaler that addresses both the reversible airway inflammation of asthma and the progressive airway damage of COPD. Your doctor will determine whether you have ACO and prescribe accordingly.

If Breztri has a corticosteroid in it, why can't it be used for asthma?

Breztri contains a corticosteroid, but the combination of three drugs and the dosing are designed for COPD, not asthma. The glycopyrrolate in Breztri is included to address mucus buildup in COPD, which is not the primary target in asthma. Using the wrong combination means you may not get the right balance of medications for your condition.

What should I do if my doctor prescribed Breztri but I think I have asthma?

Contact your doctor or pharmacist and ask them to clarify your diagnosis. It is possible your diagnosis is COPD rather than asthma, or that you have both conditions. Your doctor can explain the reasoning behind the prescription and discuss whether a different inhaler would be more appropriate.

Is Breztri dangerous for someone with asthma?

Breztri is not approved for asthma, so its safety and effectiveness in asthma have not been established through clinical trials. Using a medication outside its approved indication means you may not receive the protection you need and could experience unexpected effects. Always use the inhaler your doctor prescribed for your specific diagnosis.

Can I switch from my asthma inhaler to Breztri on my own?

No. Never switch inhalers without talking to your doctor first. Changing your maintenance inhaler without medical guidance can leave you without adequate protection and may worsen your symptoms. If you want to discuss a different inhaler, schedule an appointment with your doctor to review your options.